Cosmax Showcases PDRN and Sun Care Technologies at Shanghai Beauty Expo

Cosmax, a cosmetic ODM (research, development, and manufacturing) company, announced on May 15 that it showcased local customized formulation technologies and inner beauty solutions at a B2B beauty expo in China.

Cosmax revealed that its Chinese subsidiary, Cosmax China, completed its exhibition at the 30th China Shanghai Beauty Expo (CBE) held from December 12-14 at the Shanghai New International Expo Center. The CBE is an annual B2B beauty expo that attracts over 500,000 visitors from more than 120 countries.

The exhibition featured three themed zones: Innovation, Global, and Value Plus, focusing on local consumer demand and showcasing global research and development (R&D) capabilities. The company noted that its locally customized sun care product line garnered significant interest from buyers. A company representative stated, "The sun care line, which improves whitening and clumping based on proprietary emulsification technology, was introduced as a product line that boosted Cosmax China's related sales by approximately 120% compared to the previous year."

Cosmax also presented bio-technology-based skincare materials, including successfully commercialized bio-synthetic recombinant PDRN, enhanced absorption PDRN nanoparticle technology, and antioxidant enzyme (SOD) application technology derived from extremophile microorganisms.

Additionally, the company showcased its R&D achievements, including the award-winning '1000 Trillion Moisturizer' formulation technology, which received the CosmoPack Award this year, and over 40 bestsellers and premium research outcomes, including studies on the mechanisms of gray hair development based on organoids.

Cosmax's health supplement subsidiary, Cosmax Bio, also introduced inner beauty products. The company presented liquid health supplements utilizing collagen and sodium hyaluronate, as well as snack-form products featuring glutathione and vitamins, proposing solutions that encompass both cosmetics and inner beauty. A Cosmax representative stated, "We will provide differentiated integrated solutions to global clients by combining next-generation bio-formulation technology and inner beauty capabilities."

Meanwhile, Cosmax reported that its consolidated revenue for the first quarter of this year reached 682 billion won, a 16% increase compared to the same period last year, marking the highest quarterly revenue to date. Operating profit for the same period rose by 3% to 53 billion won.